Concepedia

Robert Don

RD

9

Publications

893

Citations

9

H-Index

1999

Active since

Affiliations

Drugs for Neglected Diseases Initiative(Current)

Scynexis (United States)

Pace University

Swiss Tropical and Public Health Institute

Haskins Laboratories

Robert Don is an author at Drugs for Neglected Diseases Initiative specializing in drug discovery, drug resistance, and medicine.

Top concepts

Publications per year

1999–2014

9

Publications

9

SCYX-7158, an Orally-Active Benzoxaborole for the Treatment of Stage 2 Human African Trypanosomiasis

Robert T. Jacobs, Bakela Nare, Stephen A. Wring et al. · PLoS neglected tropical diseases · 2011 · 294 citations · Full text

Application of a resazurin-based high-throughput screening assay for the identification and progression of new treatments for human African trypanosomiasis

Tana Bowling, Luke Mercer, Robert Don et al. · International Journal for Parasitology Drugs and Drug Resistance · 2012 · 103 citations · Full text

, , +24

Discovery of Novel Orally Bioavailable Oxaborole 6-Carboxamides That Demonstrate Cure in a Murine Model of Late-Stage Central Nervous System African Trypanosomiasis

Bakela Nare, Stephen A. Wring, Cyrus J. Bacchi et al. · Antimicrobial Agents and Chemotherapy · 2010 · 102 citations · Full text

Potential Drug Development Candidates for Human Soil-Transmitted Helminthiases

Piero Olliaro, J.P. Seiler, Annette C. Kuesel et al. · PLoS neglected tropical diseases · 2011 · 95 citations · Full text

Synergy Testing of FDA-Approved Drugs Identifies Potent Drug Combinations against Trypanosoma cruzi

Joseph D. Planer, Matthew A. Hulverson, Jennifer A. Arif et al. · PLoS neglected tropical diseases · 2014 · 90 citations · Full text

, , +18

Rows per page

1–5 of 9